Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.
about
Role of quorum sensing in bacterial infectionsA rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infectionsTreatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.The value of combining blood culture and SeptiFast data for predicting complicated bloodstream infections caused by Gram-positive bacteria or Candida species.Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort studyClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaClinical and Microbiological Determinants of Outcome in Staphylococcus aureus BacteraemiaStaphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studiesPersistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Cytokine responses to Staphylococcus aureus bloodstream infection differ between patient cohorts that have different clinical courses of infection.Predictive factors for metastatic infection in patients with bacteremia caused by methicillin-sensitive Staphylococcus aureus.Microarray-based genotyping and clinical outcomes of Staphylococcus aureus bloodstream infection: an exploratory study.Current strategies for the prevention and management of central line-associated bloodstream infections.Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysisUse of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremiaPredicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus BacteremiaThe potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.Rapid Diagnosis of Staphylococcal Catheter-Related Bacteraemia in Direct Blood Samples by Real-Time PCR.Health care associated hematogenous pyogenic vertebral osteomyelitis: a severe and potentially preventable infectious diseaseInfectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.Experimental endocarditis model of methicillin resistant Staphylococcus aureus (MRSA) in rat.Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational studyGuidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia.The value of infectious diseases consultation in Staphylococcus aureus bacteremiaIncidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus BacteremiaIncidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination databasePredictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.Impact of vancomycin on sarA-mediated biofilm formation: role in persistent endovascular infections due to methicillin-resistant Staphylococcus aureusCurrent management of bloodstream infections.Spondylodiscitis in a patient on chronic hemodialysis.Prevention and management of central line-associated bloodstream infections in hospital practice.Appropriate use of echocardiography in managing Staphylococcus aureus bacteremia.Complicated community-acquired Staphylococcus endocarditis and multiple lung abscesses: case report and review of literature.Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population.Metastatic complications of bloodstream infections in hemodialysis patients.
P2860
Q26798427-8254F32C-D313-497F-82EC-106C3305F570Q27302828-48BD9023-5ED0-49F3-B818-E0B79EC42EAFQ30449846-D2741625-5C42-4DD7-ADF2-EAACABC33874Q30586802-0FBA08CE-0565-4ECB-ABFF-BCCE8474E86EQ30667465-E5DC5C00-C25D-4B99-B6E8-5A6D39CF7AEFQ33644439-DBE015A6-7048-4FD8-A028-DC07ECD1CA65Q33688646-3162D464-7D6C-40BB-B7FC-A1C8620EE29BQ33734119-62EBC33C-1B25-4E54-A084-358040915572Q34060175-0DCED8E1-6CE6-4DBC-9608-22375459F593Q34463444-BD803A4E-09F9-44AC-98D5-2558304FCA57Q34478074-B9C02FC0-E2DC-4C99-BB32-FC19BADE9951Q34544064-63B2E75E-7AC0-48AC-A596-FEADF6E0469EQ34796934-750E5FD9-BEFE-49F7-BE68-AF414FA1FE1FQ34963643-A49D6ECB-18E4-41DE-9142-352190A61DFBQ35026591-9FA3DE7D-BDCD-4EE7-B4A6-F8D664697BC9Q35091505-43F9ED2B-9297-4CC6-A420-1C1A7369122BQ35144554-4725C2B5-EAA1-441F-9702-031E24AE553DQ35975552-5F08FDC6-A260-4254-9ABD-514BE4C6A3D0Q36020705-A431ADCB-7163-467E-9E62-8DD31CA869F9Q36115773-BA9F40AC-9B73-445E-899A-2C7D59B0D9DBQ36151876-2B659855-8BB3-4083-8EBD-6992D8D74322Q36296767-3541D79E-1F47-451C-A82C-25BEAC00676DQ36317454-F92095DD-7960-48AD-BA43-13F0EEA0EE50Q36407894-4E8FC08D-6C5B-41A3-B5B9-FC286B6F9A95Q36409465-1534238E-6B30-41B7-83C9-1FDB577C9C29Q36494439-30D097B4-C5E7-4A20-AAE8-DE82A915EB3DQ36710238-F3E092A9-FBAF-4435-AE72-E26A108CE985Q36729953-B5A88307-EF1D-44C3-B80F-BD6205942EB6Q36730006-C5F53E20-0C1C-402C-A592-F1B235628F73Q37356506-6D77B483-1117-42A3-89C4-CD5B8DA0300EQ37413851-C3A57ADC-A717-482C-BE0D-1576C77D7B63Q37538654-DBCF27C7-E181-425F-877A-315D57242060Q37671952-B6F583E0-3B0D-4815-9134-5A3EEEB42EEFQ37768418-345B79A4-846D-48CF-964B-C9449DA05C4BQ37918326-7B601588-B4A2-44BB-BDD4-EC7B323139FAQ37992486-07D9989A-094D-4186-98FF-6CB64E6D3446Q38003495-11871474-BC77-40B0-BB93-17A2B078EFEBQ38008408-3542E116-2EDF-4B1F-9EDB-F5C5830E1319Q38017278-A06B5E28-3282-45AA-B44D-96463B936174Q38070697-5071E425-B308-4676-8626-3CFAF2CDDDD0
P2860
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@en
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@nl
type
label
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@en
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@nl
prefLabel
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@en
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@nl
P2093
P2860
P50
P356
P1476
Risk factors for hematogenous ...... phylococcus aureus bacteremia.
@en
P2093
Anita Justice
Catrin Moore
Christopher W Woods
Daniel K Benjamin
G Ralph Corey
L Barth Reller
Steven Campbell
P2860
P304
P356
10.1086/427806
P407
P577
2005-02-04T00:00:00Z